Understanding the Financial Needs Following Diagnosis of Breast Cancer in a Setting with Universal Health Coverage.


Journal

The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837

Informations de publication

Date de publication:
06 2020
Historique:
received: 02 06 2019
accepted: 05 12 2019
pubmed: 11 1 2020
medline: 22 6 2021
entrez: 11 1 2020
Statut: ppublish

Résumé

A diagnosis of cancer negatively impacts the financial wellbeing of affected individuals as well as their households. We aimed to gain an in-depth understanding of the financial needs following diagnosis of breast cancer in a middle-income setting with universal health coverage. Twelve focus group discussions (n = 64) were conducted with women with breast cancer from two public and three private hospitals. This study specifically focused on (a) health costs, (b) nonhealth costs, (c) employment and earnings, and (d) financial assistance. Thematic analysis was used. Financial needs related to cancer treatment and health care varied according to the participant's socioeconomic background and type of medical insurance. Although having medical insurance alleviated cancer treatment-related financial difficulties, limited policy coverage for cancer care and suboptimal reimbursement policies were common complaints. Nonhealth expenditures were also cited as an important source of financial distress; patients from low-income households reported transport and parking costs as troublesome, with some struggling to afford basic necessities, whereas participants from higher-income households mentioned hired help, special food and/or supplements and appliances as expensive needs following cancer. Needy patients had a hard time navigating through the complex system to obtain financial support. Irrespective of socioeconomic status, reductions in household income due to loss of employment and/or earnings were a major source of economic hardship. There are many unmet financial needs following a diagnosis of (breast) cancer even in settings with universal health coverage. Health care professionals may only be able to fulfill these unmet needs through multisectoral collaborations, catalyzed by strong political will. As unmet financial needs exist among patients with cancer across all socioeconomic groups, including for patients with medical insurance, financial navigation should be prioritized as an important component of cancer survivorship services, including in the low- and middle-income settings. Apart from assisting survivors to understand the costs of cancer care, navigate the complex system to obtain financial assistance, or file health insurance claims, any planned patient navigation program should also provide support to deal with employment-related challenges and navigate return to work. It is also echoed that costs for essential personal items (e.g., breast prostheses) should be covered by health insurance or subsidized by the government.

Sections du résumé

BACKGROUND
A diagnosis of cancer negatively impacts the financial wellbeing of affected individuals as well as their households. We aimed to gain an in-depth understanding of the financial needs following diagnosis of breast cancer in a middle-income setting with universal health coverage.
MATERIALS AND METHODS
Twelve focus group discussions (n = 64) were conducted with women with breast cancer from two public and three private hospitals. This study specifically focused on (a) health costs, (b) nonhealth costs, (c) employment and earnings, and (d) financial assistance. Thematic analysis was used.
RESULTS
Financial needs related to cancer treatment and health care varied according to the participant's socioeconomic background and type of medical insurance. Although having medical insurance alleviated cancer treatment-related financial difficulties, limited policy coverage for cancer care and suboptimal reimbursement policies were common complaints. Nonhealth expenditures were also cited as an important source of financial distress; patients from low-income households reported transport and parking costs as troublesome, with some struggling to afford basic necessities, whereas participants from higher-income households mentioned hired help, special food and/or supplements and appliances as expensive needs following cancer. Needy patients had a hard time navigating through the complex system to obtain financial support. Irrespective of socioeconomic status, reductions in household income due to loss of employment and/or earnings were a major source of economic hardship.
CONCLUSION
There are many unmet financial needs following a diagnosis of (breast) cancer even in settings with universal health coverage. Health care professionals may only be able to fulfill these unmet needs through multisectoral collaborations, catalyzed by strong political will.
IMPLICATIONS FOR PRACTICE
As unmet financial needs exist among patients with cancer across all socioeconomic groups, including for patients with medical insurance, financial navigation should be prioritized as an important component of cancer survivorship services, including in the low- and middle-income settings. Apart from assisting survivors to understand the costs of cancer care, navigate the complex system to obtain financial assistance, or file health insurance claims, any planned patient navigation program should also provide support to deal with employment-related challenges and navigate return to work. It is also echoed that costs for essential personal items (e.g., breast prostheses) should be covered by health insurance or subsidized by the government.

Identifiants

pubmed: 31922332
doi: 10.1634/theoncologist.2019-0426
pmc: PMC7288648
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-504

Informations de copyright

© AlphaMed Press 2020.

Références

J Oncol Pract. 2015 Mar;11(2):145-50
pubmed: 25515717
Br J Gen Pract. 2004 Aug;54(505):589-94
pubmed: 15296557
Eval Rev. 2003 Oct;27(5):563-8
pubmed: 14531319
Eur J Cancer Care (Engl). 2007 Jan;16(1):17-25
pubmed: 17227349
J Pain Symptom Manage. 2019 Mar;57(3):646-660.e1
pubmed: 30550833
PLoS One. 2015 Oct 09;10(10):e0139952
pubmed: 26451732
J Oncol Pract. 2019 Jun;15(6):e537-e546
pubmed: 31112479
Eur J Cancer. 2005 Nov;41(17):2613-9
pubmed: 16226458
JAMA Netw Open. 2018 Nov 2;1(7):e184796
pubmed: 30646372
Clin Lung Cancer. 2019 Jul;20(4):231-236
pubmed: 30797721
Int J Health Care Qual Assur. 2011;24(7):506-22
pubmed: 22204085
PLoS One. 2013 Nov 11;8(11):e77549
pubmed: 24244279
JNCI Cancer Spectr. 2019 Oct 21;3(4):pkz061
pubmed: 32337486
J Health Care Poor Underserved. 2009 Aug;20(3):721-8
pubmed: 19648700
Oncologist. 2013;18(4):381-90
pubmed: 23442307
JAMA Oncol. 2017 Nov 1;3(11):1582-1584
pubmed: 28796862
Cancer Nurs. 2003 Jun;26(3):179-86
pubmed: 12832950
Support Care Cancer. 2019 Jun;27(6):2221-2228
pubmed: 30315427
Asia Pac J Oncol Nurs. 2017 Jul-Sep;4(3):250-258
pubmed: 28695172
Patient. 2017 Jun;10(3):295-309
pubmed: 27798816
Oncologist. 2015 Dec;20(12):1378-85
pubmed: 26512045
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
BMC Med. 2015 Aug 18;13:190
pubmed: 26282128
Health Aff (Millwood). 2016 May 1;35(5):838-46
pubmed: 27140990
J Cancer Surviv. 2019 Feb;13(1):10-20
pubmed: 30357537
Support Care Cancer. 2014 Nov;22(11):3045-52
pubmed: 24912858
Cancer. 2010 Jul 15;116(14):3493-504
pubmed: 20549763
Support Care Cancer. 2013 Jan;21(1):107-17
pubmed: 22987093
J Oncol Pract. 2018 Feb;14(2):e122-e129
pubmed: 29272200
J Neurooncol. 2007 Dec;85(3):329-38
pubmed: 17581698
BMC Gastroenterol. 2012 Jun 07;12:62
pubmed: 22676509

Auteurs

Yek-Ching Kong (YC)

Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Li-Ping Wong (LP)

Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Chiu-Wan Ng (CW)

Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Nur Aishah Taib (NA)

Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Nanthini Thevi Bhoo-Pathy (NT)

Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Mastura Mohd Yusof (MM)

Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.

Azlina Firzah Aziz (AF)

Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.

Prathepamalar Yehgambaram (P)

Department of Radiotherapy and Oncology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.

Wan Zamaniah Wan Ishak (WZW)

Department of Clinical Oncology, University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Cheng-Har Yip (CH)

Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.

Nirmala Bhoo-Pathy (N)

Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH